Samarth Kulkarni, Chief Executive Officer

CRSP 182,989 shares

The estimated Net Worth of Samarth Kulkarni is at least $39,789,128.16. Samarth Kulkarni owns over 182,989 units of CRISPR Therapeutics AG stock worth over $39,789,128.16.

Transaction DateCompanySharesTypeOwnedPriceValuePost Value
15th January 2021CRSP - CRISPR Therapeutics AG1,304Open or private sale182,989$217.44$283,541.76$39,789,128.16
15th January 2021CRSP - CRISPR Therapeutics AG1,708Open or private sale184,293$216.50$369,782.00$39,899,434.50
15th January 2021CRSP - CRISPR Therapeutics AG1,700Open or private sale186,001$214.68$364,956.00$39,930,694.68
15th January 2021CRSP - CRISPR Therapeutics AG5,623Open or private sale187,701$213.71$1,201,691.33$40,113,580.71
15th January 2021CRSP - CRISPR Therapeutics AG6,525Open or private sale193,324$212.75$1,388,193.75$41,129,681.00
15th January 2021CRSP - CRISPR Therapeutics AG3,140Open or private sale199,849$211.83$665,146.20$42,334,013.67
15th January 2021CRSP - CRISPR Therapeutics AG20,000Exercise of derivative202,989$1.81$36,200.00$367,410.09
29th December 2020CRSP - CRISPR Therapeutics AG13,800Exercise of derivative182,989$1.81$24,978.00$331,210.09
10th December 2020CRSP - CRISPR Therapeutics AG600Open or private sale169,189$144.97$86,982.00$24,527,329.33
10th December 2020CRSP - CRISPR Therapeutics AG2,100Open or private sale169,789$143.71$301,791.00$24,400,377.19
10th December 2020CRSP - CRISPR Therapeutics AG6,766Open or private sale171,889$142.75$965,846.50$24,537,154.75
10th December 2020CRSP - CRISPR Therapeutics AG5,034Open or private sale178,655$141.98$714,727.32$25,365,436.90
10th December 2020CRSP - CRISPR Therapeutics AG5,500Open or private sale183,689$141.17$776,435.00$25,931,376.13
10th December 2020CRSP - CRISPR Therapeutics AG20,000Exercise of derivative189,189$1.81$36,200.00$342,432.09
1st December 2020CRSP - CRISPR Therapeutics AG779Payment by withholding169,189$129.58$100,942.82$21,923,510.62
1st March 2019CRSP - CRISPR Therapeutics AG748Payment by withholding166,542$39.97$29,897.56$6,656,683.74
29th April 2019CRSP - CRISPR Therapeutics AG20,000Open or private sale166,542$42.03$840,600.00$6,999,760.26
29th April 2019CRSP - CRISPR Therapeutics AG20,000Exercise of derivative186,542$1.81$36,200.00$337,641.02
1st June 2019CRSP - CRISPR Therapeutics AG741Payment by withholding165,801$35.57$26,357.37$5,897,541.57
17th June 2019CRSP - CRISPR Therapeutics AG20,000Open or private sale165,801$46.00$920,000.00$7,626,846.00
17th June 2019CRSP - CRISPR Therapeutics AG20,000Exercise of derivative185,801$1.81$36,200.00$336,299.81
1st September 2019CRSP - CRISPR Therapeutics AG740Payment by withholding165,061$46.21$34,195.40$7,627,468.81
1st December 2019CRSP - CRISPR Therapeutics AG741Payment by withholding164,320$71.65$53,092.65$11,773,528.00
16th December 2019CRSP - CRISPR Therapeutics AG8,000Exercise of derivative172,320$1.81$14,480.00$311,899.20
2nd March 2020CRSP - CRISPR Therapeutics AG794Payment by withholding171,526$52.74$41,875.56$9,046,281.24
20th May 2020CRSP - CRISPR Therapeutics AG10,693Open or private sale171,526$65.28$698,039.04$11,197,217.28
20th May 2020CRSP - CRISPR Therapeutics AG10,693Exercise of derivative182,219$1.81$19,354.33$329,816.39
19th May 2020CRSP - CRISPR Therapeutics AG4,307Open or private sale171,526$65.16$280,644.12$11,176,634.16
19th May 2020CRSP - CRISPR Therapeutics AG4,307Exercise of derivative175,833$1.81$7,795.67$318,257.73
2nd June 2020CRSP - CRISPR Therapeutics AG779Payment by withholding170,747$66.26$51,616.54$11,313,696.22
1st June 2020CRSP - CRISPR Therapeutics AG5,575Open or private sale171,526$65.26$363,824.50$11,193,786.76
1st June 2020CRSP - CRISPR Therapeutics AG9,300Open or private sale177,101$64.61$600,873.00$11,442,495.61
1st June 2020CRSP - CRISPR Therapeutics AG2,400Open or private sale186,401$63.57$152,568.00$11,849,511.57
1st June 2020CRSP - CRISPR Therapeutics AG17,275Exercise of derivative188,801$1.81$31,267.75$341,729.81
2nd September 2020CRSP - CRISPR Therapeutics AG779Payment by withholding169,968$94.15$73,342.85$16,002,487.20